Kyverna Therapeutics, Inc. Common Stock (KYTX) — Defensive Interval Ratio
Kyverna Therapeutics, Inc. Common Stock (KYTX) has a Defensive Interval Ratio of 2512 days as of March 2026. Defensive assets of $204.25 Million (cash $-, short-term investments $204.25 Million, receivables $-) cover 2512 days of daily cash needs of $81.30K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Kyverna Therapeutics, Inc. Common Stock Defensive Interval Ratio (2021–2025)
This chart shows how Kyverna Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 2512 days, meaning defensive assets of $204.25 Million can fund 2512 days of operations without new revenue. For the complete balance sheet picture, see Kyverna Therapeutics, Inc. Common Stock balance sheet assets.
Annual Defensive Interval Ratio for Kyverna Therapeutics, Inc. Common Stock (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for Kyverna Therapeutics, Inc. Common Stock from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See KYTX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1552 days | $155.16 Million | $99.96K/day | $- | $155.16 Million | ▼ -495 days |
| 2024 | 2048 days | $189.36 Million | $92.48K/day | $- | $189.36 Million | ▲ +1627 days |
| 2023 | 421 days | $22.90 Million | $54.41K/day | $- | $22.90 Million | ▲ +6 days |
| 2022 | 415 days | $13.59 Million | $32.75K/day | $- | $13.59 Million | ▲ +415 days |
| 2021 | 0 days | $0.00 | $43.64K/day | $- | $0.00 | — |